Decibel Therapeutics, Inc. 3 SEC Filings

Filed On	Filing
21 Mar 2023	Form 3: Kapusta Matthew C, Director No securities owned
12 Oct 2022	Form 3: Murphy James B, See Remarks No securities owned
12 Oct 2022	Form 3: Mclaughlin Kevin F, Director No securities owned
06 Dec 2021	Form 3: Finger Alison Cecily, Director No securities owned
06 Dec 2021	Form 3: Nochur Sara, Director No securities owned
18 Aug 2021	Form 3: Hu Cynthia W., General Counsel No securities owned
03 Jun 2021	Form 3: Carson William H., Director No securities owned
08 Mar 2021	Form 3: Schroder Adveq Technology Ix S.c.s., 10% owner and 3 others
12 Feb 2021	Form 3: Third Rock Ventures III, L.p., 10% owner and 5 others Holds 47,169 shares of Common Stock
11 Feb 2021	Form 3: Leiderman Elisabeth, See Remarks
11 Feb 2021	Form 3: Trask Anna, See Remarks Holds 18,188 shares of Common Stock
11 Feb 2021	Form 3: Vigliotta Ronald, See Remarks Holds 6,587 shares of Common Stock
11 Feb 2021	Form 3: Glaxosmithkline Plc, Director
11 Feb 2021	Form 3: Poon Christine A, Director
11 Feb 2021	Form 3: Longevity Fund 2 Lp, 10% owner
11 Feb 2021	Form 3: Gv 2019 GP, L.l.c., 10% owner and 2 others
11 Feb 2021	Form 3: Gv 2017 GP, L.l.c., 10% owner and 2 others
11 Feb 2021	Form 3: Gv 2016 GP, L.l.c., 10% owner and 2 others
11 Feb 2021	Form 3: Regeneron PHARMACEUTICALS, Inc., 10% owner
11 Feb 2021	Form 3: Casdin Partners Master Fund, L.p., 10% owner

Comments